Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
MindMed Ready To Take LSD Therapy Into Phase III For Anxiety
Treatment Infrastructure In Place Due To J&J’s Spravato
Mar 07 2024
•
By
Mandy Jackson
Half of anxiety patients seeking treatment do not respond to first-line drugs • Source: Shutterstock
More from Clinical Trials
More from R&D